Genomic Valley Biotech Ltd — Updates, 07-08-2025: Company Update

Genomic Valley Biotech's board meeting approved the financial results for the quarter ended June 30, 2025. The company reported revenue from operations of Rs. 0.61 Cr and a profit of Rs. 0.02 Cr for the quarter. The board also appointed M/s. SBR & Co. LLP as Secretarial Auditors for FY 25-30 and Mr. Navjyoti Kumar Jha as Internal Auditor for FY 2025-26. Furthermore, Mr. Yogesh Agrawal was re-appointed as Chairman & Managing Director for five years from September 07, 2025, ensuring leadership continuity for the company.